Abstract
Understanding molecular recognition of small molecules by proteins in atomistic detail is key for drug design. Molecular docking is a widely used computational method to mimic ligand-protein association in silico. However, predicting conformational changes occurring in proteins upon ligand binding is still a major challenge. Ensemble docking approaches address this issue by considering a set of different conformations of the protein obtained either experimentally or from computer simulations, e.g., molecular dynamics. However, holo structures prone to host (the correct) ligands are generally poorly sampled by standard molecular dynamics simulations of the apo protein. In order to address this limitation, we introduce a computational approach based on metadynamics simulations called ensemble docking with enhanced sampling of pocket shape (EDES) that allows holo-like conformations of proteins to be generated by exploiting only their apo structures. This is achieved by defining a set of collective variables that effectively sample different shapes of the binding site, ultimately mimicking the steric effect due to the ligand. We assessed the method on three challenging proteins undergoing different extents of conformational changes upon ligand binding. In all cases our protocol generates a significant fraction of structures featuring a low RMSD from the experimental holo geometry. Moreover, ensemble docking calculations using those conformations yielded in all cases native-like poses among the top-ranked ones.
Original language | English |
---|---|
Pages (from-to) | 1515-1528 |
Number of pages | 14 |
Journal | Journal of Chemical Information and Modeling |
Volume | 59 |
Issue number | 4 |
DOIs | |
Publication status | Published - 22 Apr 2019 |
Funding
*E-mail: [email protected]; [email protected]. ORCID Giuliano Malloci: 0000-0002-5985-257X Fabio Pietrucci: 0000-0002-4892-2667 Alexandre M. J. J. Bonvin: 0000-0001-7369-1322 Attilio V. Vargiu: 0000-0003-4013-8867 Author Contributions A.B. and A.V.V. designed research with contributions of all authors. A.B. performed MD simulations. G.M. performed druggability calculations. A.M.J.J.B. performed docking calculations with HADDOCK. A.V.V. performed docking calculations with AutoDock4. All of the authors contributed analysis tools and analyzed the data. The manuscript was written with contributions of and approved by all of the authors. Funding A.B. gratefully acknowledges the Sardinia Regional Government for the financial support of his Ph.D. scholarship (P.O.R. Sardegna F.SE., Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2014−2020Axis III Education and Training, Thematic Goal 10, Priority of Investment 10ii, Specific Goal 10.5., Action Partnership Agreement 10.5.12). This work was done as part of the BioExcel CoE (www.bioexcel.eu), a project funded by the European Union Horizon 2020 Program under Grant Agreements 675728 and 823830. The research leading to the results discussed here was partly conducted as part of the Translocation Consortium (www.translocation.eu) and received support from the Innovative Medicines Initiative Joint Undertaking under Grant Agreement 115525, resources that are composed of financial contributions from the European Union’s Seventh Framework Programme (FP7/2007−2013) and EFPIA companies in-kind contributions. Notes The authors declare no competing financial interest.